NEW YORK, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system ...
Auvelity (dextromethorphan/bupropion) is a prescription drug that’s used to treat depression. The drug comes as an extended-release tablet. It’s usually taken ...
AUVELITY is a novel, oral, NMDA receptor antagonist with multimodal activity approved for the treatment of MDD in adults. AUVELITY is a proprietary extended-release oral tablet containing ...
Shares of Axsome Therapeutics AXSM jumped 20.2% on Monday after the company announced that it has entered into a settlement agreement with Teva Pharmaceuticals TEVA related to patents for the ...
How Does Auvelity Work for Major Depressive Disorder? Auvelity helps to lessen the symptoms of major depressive disorder through a combination of two medicines that have antidepressant effects.
Taking Auvelity with certain medications like MAOIs, stimulants, and opioids can increase the risk of serious side effects, including seizures and serotonin syndrome. Certain health conditions, such ...
New data on Auvelity’s impact on quality of life, measured by the Q-LES-Q-SF, in patients who had received at least one prior treatment during their current depressive episode Data on Auvelity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results